2008
DOI: 10.1038/sj.bjc.6604118
|View full text |Cite
|
Sign up to set email alerts
|

Significant decrease of adenocarcinoma in situ not reflected in cervical adenocarcinoma incidence in the Netherlands 1989–2003

Abstract: Over the period 1989 -2003, the incidence of cervical adenocarcinoma (n ¼ 1615) was stable whereas that of cervical adenocarcinoma in situ (n ¼ 1884) significantly decreased (P ¼ 0.008), mainly caused by adenocarcinoma in situ lesions with a concurrent squamous dysplasia.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
3
2

Year Published

2009
2009
2017
2017

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 10 publications
(5 citation statements)
references
References 33 publications
0
3
2
Order By: Relevance
“…The increase in AIS was predominant in women in the 25–39 age groups. This finding is not in accordance with the trends found by van de Nieuwenhof et al ,. who described a decrease in the adenocarcinoma in situ incidence with a stable adenocarcinoma incidence in the period of 1989–2003.…”
Section: Discussioncontrasting
confidence: 98%
See 2 more Smart Citations
“…The increase in AIS was predominant in women in the 25–39 age groups. This finding is not in accordance with the trends found by van de Nieuwenhof et al ,. who described a decrease in the adenocarcinoma in situ incidence with a stable adenocarcinoma incidence in the period of 1989–2003.…”
Section: Discussioncontrasting
confidence: 98%
“…By using the Dutch national pathology database (PALGA) and scrutinizing all records with the specific terms mentioned as mentioned above, we are convinced that our dataset is more complete. This can partly explain the difference between this study and the study by van de Nieuwenhof .…”
Section: Discussioncontrasting
confidence: 93%
See 1 more Smart Citation
“…There have been some studies to date which have examined risk factors for, incidence trends of, HPV prevalence in adenocarcinoma. However, most of these studies were based on pooled analyses of data from epidemiological studies,4, 11 extraction of data from cancer registries5, 12–14 or retrospective collection and examination of archival tissue 15–22. The peak age of incidence of AIS among women has been estimated as 35–39 years, and the duration of progression from AIS to adenocarcinoma has been estimated to be 5–13 years 7.…”
mentioning
confidence: 99%
“…Precancerous stages of adenocarcinoma are less clearly understood and may not be as long as for squamous carcinoma. Indeed, some authors have argued that the lack of correlation between in situ disease and changes in adenocarcinoma rates implies that screening may have no impact on adenocarcinoma rates 25–27. Our results suggest that screening has a small but significant impact on the incidence of adenocarcinoma.…”
Section: Discussionmentioning
confidence: 53%